Hear about Spectrum’s involvement with the MM+M Pitch Slam, how to pitch virtually and why Spectrum is growing by leaps and bounds this year.
AstraZeneca vaccine results impress; U.S. to begin distributing Regeneron antibody therapy; Merck acquires OncoImmune, maker of a COVID treatment.
The federal government and the private sector will have their work cut out for them encouraging people to get the vaccine, and telling them how to do so.
Regeneron’s experimental coronavirus treatment receives emergency use approval; Pfizer/BioNTech request emergency use approval for COVID-19 vaccine; Vaccine could be distributed as soon as 24-hours after receiving approval.
HHS pilot program brings rapid, POC coronavirus tests to five states; CDC: Americans should not travel for Thanksgiving; J&J makes a $100 million diversity pledge.
Plus people moves at EmpiRx Health, Open Health Group and CMI/Compas.
Cahill assumes the role on January 1, as current chief exec Wendy Lund departs for a comms role at Merck spinoff Organon.
Pfizer/BioNTech vaccine proves safe and effective; COVID death and hospitalization numbers surge; Biden taps pharma lobbyist for administration.
Washington healthcare policy insider Terry Haines offers his thoughts on COVID relief, the future of the Affordable Care Act and more.
Dr. Charlotte Jones-Burton, VP of Otsuka and president and co-founder of WOCIP, weighs in on recent statements concerning Vice-President-elect Kamala Harris’ Black heritage, and offers her take on other news.